- Tytuł:
- Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
- Autorzy:
- Temat:
-
THERAPEUTIC use of antineoplastic agents
THERAPEUTIC use of monoclonal antibodies
BREAST tumorsCANCER patients
COMBINATION drug therapy
CLINICAL trials
COMBINED modality therapy
DRUG efficacy
MEDICAL cooperation
METASTASIS
PATIENT safety
RESEARCH
SURVIVAL analysis (Biometry)
EPIDERMAL growth factor receptors
ERIBULIN - Źródło:
- Investigational New Drugs; 2021, Vol. 39 Issue 1, p217-225, 9p
Czasopismo naukowe